A new study published in Cellular and Molecular Neurobiology demonstrates that diabetes mellitus significantly impairs the brain’s ability to repair itself after an ischemic stroke. The research, conducted on a type 1 diabetes mouse model, reveals that diabetic conditions hinder both the formation of new blood vessels and the maintenance of the blood-brain barrier. The study identifies specific molecular mechanisms within the Slit2/Robo/CRTC1 signaling pathway that are dysregulated by diabetes, offering a potential target for future therapeutic interventions aimed at improving recovery in diabetic populations.
The research team established a type 1 diabetes model in six-week-old mice by administering intraperitoneal injections of streptozotocin at a dose of 60 mg/kg per day for five consecutive days. The success of the diabetic induction was confirmed through blood glucose testing two weeks after the final injection. Following the establishment of the diabetic state, the researchers induced focal ischemic stroke using a photothrombosis model.
To evaluate the functional consequences of these vascular changes, the investigators assessed neurological recovery using a combination of standard behavioral tests. These included neurological scoring, the Rotarod test, and the foot-fault test. The results indicated that diabetic mice experienced significantly impaired sensorimotor recovery compared to their non-diabetic counterparts.
Post-stroke neovascularization was quantified via lectin injection. The study found that diabetes hindered reparative neovascularization in the peri-infarct area.
The integrity of the blood-brain barrier was evaluated through multiple metrics. The researchers measured IgG leakage and assessed pericyte coverage. Additionally, the expression of tight junction proteins, specifically Zo-1, occludin, and claudin-5, was analyzed. The results showed that diabetes exacerbated BBB disruption, evidenced by increased IgG leakage and diminished pericyte coverage. Furthermore, there was a reduced expression of occludin and claudin-5. These findings collectively demonstrate that diabetes compromises the structural and functional integrity of the blood-brain barrier following a stroke.
At the molecular level, the study investigated the Slit2/Robo/CRTC1 signaling pathway. Protein expression within this pathway was analyzed at 1, 7, and 14 days post-stroke using immunofluorescence and western blotting. The data revealed that diabetes led to a decrease in Robo1 expression and an increase in Robo4 expression, while Slit2 levels remained unchanged.
The study also found that diabetes further suppressed the expression of the co-transcription factor CRTC1 following the ischemic event.
By identifying specific molecular targets within the Slit2/Robo/CRTC1 pathway, the study provides a foundation for developing therapies that could enhance stroke recovery in diabetic patients.
Subject of Research: Impact of diabetes on post-stroke angiogenesis and blood-brain barrier integrity in a mouse model
Article Title: Diabetes Impairs Post-stroke Angiogenesis and BBB Integrity Accompanied by Dysregulated Slit2/Robo-CRTC1 Pathway
Article References: Wang, Y., Shi, X., Zhao, X., Lu, X., Gu, J., Guo, H., Wang, Y., Wu, X., Xu, C., Shen, M., Shen, Y., Guo, C., Hao, Y., Qian, S., & Jin, X. (2026). Diabetes Impairs Post-stroke Angiogenesis and BBB Integrity Accompanied by Dysregulated Slit2/Robo-CRTC1 Pathway. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-026-01811-w
Image Credits: AI Generated
DOI: 10.1007/s10571-026-01811-w
Keywords: diabetes, stroke, angiogenesis, blood-brain barrier, Slit2/Robo/CRTC1, neurorestoration, mouse model, ischemic injury, Impairs, Post-stroke, Integrity, Accompanied
News Source: Cassandra Pierce. (November 10, 2026). Diabetes Disrupts Stroke Recovery Pathways in Mouse Model. Scienmag.



